• 2,99 €

Descripción editorial

Most cells in the human body are committed to fulfilling a single function. In contrast, embryonic stem cells have the ability to become over 200 distinct cell types. Because of this distinctive characteristic, embryonic stem cells hold vast promise to treat a variety of diseases and disorders. Nevertheless, scientific experts concede that substantial advances in basic biology and clinical technique are essential before embryonic stem cells are readily available for clinical use. Despite the lack of safety and efficacy testing in humans, there are clinics around the world charging patients thousands of dollars for embryonic stem cell-based therapy. As a result, scientists have reported instances of patients suffering adverse outcomes after receiving unregulated stem cell-based therapies. Recognizing the global nature of science and medicine, this Note explores various solutions the United Nations can take to regulate the use of embryonic stem cells in clinical practice. I. INTRODUCTION

GÉNERO
Técnicos y profesionales
PUBLICADO
2011
1 de enero
IDIOMA
EN
Inglés
EXTENSIÓN
69
Páginas
EDITORIAL
Case Western Reserve University School of Law
TAMAÑO
477,9
KB

Más libros de Case Western Reserve Journal of International Law